221 related articles for article (PubMed ID: 26130517)
21. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
[TBL] [Abstract][Full Text] [Related]
22. The Adh adhesin domain is required for trimeric autotransporter Apa1-mediated Actinobacillus pleuropneumoniae adhesion, autoaggregation, biofilm formation and pathogenicity.
Wang L; Qin W; Yang S; Zhai R; Zhou L; Sun C; Pan F; Ji Q; Wang Y; Gu J; Feng X; Du C; Han W; Langford PR; Lei L
Vet Microbiol; 2015 May; 177(1-2):175-83. PubMed ID: 25818350
[TBL] [Abstract][Full Text] [Related]
23. Determination of minimum inhibitory and minimum bactericidal concentrations of tiamulin against field isolates of Actinobacillus pleuropneumoniae.
Pridmore A; Burch D; Lees P
Vet Microbiol; 2011 Aug; 151(3-4):409-12. PubMed ID: 21497460
[TBL] [Abstract][Full Text] [Related]
24. Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae.
Tanigawa M; Sawada T
J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):513-8. PubMed ID: 12485363
[TBL] [Abstract][Full Text] [Related]
25. The CpxA/CpxR Two-Component System Affects Biofilm Formation and Virulence in
Li H; Liu F; Peng W; Yan K; Zhao H; Liu T; Cheng H; Chang P; Yuan F; Chen H; Bei W
Front Cell Infect Microbiol; 2018; 8():72. PubMed ID: 29662838
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae.
Yoshimura H; Takagi M; Ishimura M; Endoh YS
Vet Res Commun; 2002 Jan; 26(1):11-9. PubMed ID: 11860083
[TBL] [Abstract][Full Text] [Related]
27. Effect of bovine apo-lactoferrin on the growth and virulence of Actinobacillus pleuropneumoniae.
Luna-Castro S; Aguilar-Romero F; Samaniego-Barrón L; Godínez-Vargas D; de la Garza M
Biometals; 2014 Oct; 27(5):891-903. PubMed ID: 24878848
[TBL] [Abstract][Full Text] [Related]
28. Rhein kills
Ding H; Bai Y; Luo W; Li H; Zhu C; Zhao X; Sun H; Wen Y; Zhang W; Zhang S; Wen B; Wang R; Zhang L; Liu X; Shen J; Hu J; Wang L; Bai Y; Liao C; Wu Y; Wu X; Ding K
J Med Microbiol; 2024 Apr; 73(4):. PubMed ID: 38668646
[No Abstract] [Full Text] [Related]
29. Serotypes, antimicrobial susceptibility, and minimal inhibitory concentrations of Actionbacillus pleuropneumoniae isolated from slaughter pigs in Taiwan (2002-2007).
Yang CY; Lin CN; Lin CF; Chang TC; Chiou MT
J Vet Med Sci; 2011 Feb; 73(2):205-8. PubMed ID: 20948169
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests.
Aarestrup FM; Jensen NE
Vet Microbiol; 1999 Feb; 64(4):299-305. PubMed ID: 10063535
[TBL] [Abstract][Full Text] [Related]
31. Biological characteristics of mechanosensitive channels MscS and MscL in
Wan J; Dai L; Xiao H; Zhang W; Zhang R; Xie T; Jia Y; Gao X; Huang J; Liu F
J Bacteriol; 2024 Mar; 206(3):e0042923. PubMed ID: 38391161
[No Abstract] [Full Text] [Related]
32. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
33. Use of recombinant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA.
Dreyfus A; Schaller A; Nivollet S; Segers RP; Kobisch M; Mieli L; Soerensen V; Hüssy D; Miserez R; Zimmermann W; Inderbitzin F; Frey J
Vet Microbiol; 2004 Apr; 99(3-4):227-38. PubMed ID: 15066725
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan.
Chang CF; Yeh TM; Chou CC; Chang YF; Chiang TS
Vet Microbiol; 2002 Jan; 84(1-2):169-77. PubMed ID: 11731169
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
[TBL] [Abstract][Full Text] [Related]
36. Regulation of pga operon expression and biofilm formation in Actinobacillus pleuropneumoniae by sigmaE and H-NS.
Bossé JT; Sinha S; Li MS; O'Dwyer CA; Nash JH; Rycroft AN; Kroll JS; Langford PR
J Bacteriol; 2010 May; 192(9):2414-23. PubMed ID: 20207760
[TBL] [Abstract][Full Text] [Related]
37. Infection dynamics and acute phase response of an Actinobacillus pleuropneumoniae field isolate of moderate virulence in pigs.
Gómez-Laguna J; Islas A; Muñoz D; Ruiz A; Villamil A; Carrasco L; Quezada M
Vet Microbiol; 2014 Oct; 173(3-4):332-9. PubMed ID: 25201629
[TBL] [Abstract][Full Text] [Related]
38. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade.
Gutiérrez-Martín CB; del Blanco NG; Blanco M; Navas J; Rodríguez-Ferri EF
Vet Microbiol; 2006 Jun; 115(1-3):218-22. PubMed ID: 16431040
[TBL] [Abstract][Full Text] [Related]
39. Actinobacillus pleuropneumoniae genes expression in biofilms cultured under static conditions and in a drip-flow apparatus.
Tremblay YD; Deslandes V; Jacques M
BMC Genomics; 2013 May; 14():364. PubMed ID: 23725589
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
